• Home
  • Drug Delivery
    • Overview
    • Durable Coatings
    • Biodegradable Coatings
    • Microparticles
    • Implants
    • Protein Delivery
    • Biodegradable Polymer Supply
  • Surface Modification
    • Overview
    • Advanced Hydrophilic Coating
    • Biocompatibility & Prohealing Coatings
    • Cell Encapsulation

  • In Vitro Technologies
    • Overview
    • Protein Stabilization Reagents
    • BioFX® Substrates
    • Autoimmune Antigens
    • SurModics® Synthetic ECM
    • CodeLink® Activated Slides
  • Clinical Applications
    • Overview
    • Cardiovascular
    • Ophthalmology
    • Orthopedics
  • About Us
    • Overview
    • Message from the CEO
    • Mission & Values
    • Community Relations
    • History
    • Officers
    • Board of Directors
    • Customer Relationships
    • Business Development
  • Technologies
    • Overview
    • Drug Delivery
    • Surface Modification
    • In Vitro Technologies
  • Applications
    • Overview
    • Cardiovascular
    • Ophthalmology
    • Orthopedics
  • Investors
    • Investor Overview
    • Officers
    • Directors
    • Stock Performance
    • Financial Highlights
    • News Releases
    • Analyst Coverage
    • Annual Reports
    • Corporate Governance
    • SEC Filings
    • Conference Calls
    • IR Events
    • Presentations
    • Investor Inquiries
  • News & Events
    • Events Calendar
    • News Releases
  • Careers
    • Overview
    • Open Positions
    • Network with SurModics
    • Company Culture
    • Benefits
    • Business Overview
  • Home
  • Contact Us


Recent News

SurModics Purchases Additional Facility to Expand Brookwood Pharmaceuticals' Development and Manufacturing Capacity

SurModics Reports Record Total and Legacy Business Revenue in Second Quarter 2008




 


Privacy Policy | Terms of Use | © 2008 Surmodics, All Rights Reserved